Skip to content
- Human metastatic cholangiocarcinoma patient-derived xenografts and tumoroids for preclinical drug evaluation.
- Serra-Camprubí Q, Verdaguer H, Oliveros W, Lupión-Garcia N, Llop-Guevara A, Molina C, Vila-Casadesús M, Turpin A, Neuzillet C, Frigola J, Querol J, Yáñez-Bartolomé M, Castet F, Fabregat-Franco C, Escudero-Iriarte C, Escorihuela M, Arenas EJ, Bernado-Morales C, Haro N, Giles FJ, Pozo OJ, Miquel JM, Nuciforo PG, Vivancos A, Melé M, Serra V, Arribas J, Tabernero J, Peiró S, Macarulla T, Tian TV.
- Clin Cancer Res. 2022 Nov 14:CCR-22-2551. doi: 10.1158/1078-0432.CCR-22-2551. Epub ahead of print.
- Comparing Characteristics of Pelvic High-grade Serous Carcinomas with and without Breast Cancer Gene Variants on MR Imaging.
- Saida T, Shikama A, Mori K, Ishiguro T, Minaguchi T, Satoh T, Nakajima T.
- Magn Reson Med Sci. 2022 Nov 12. doi: 10.2463/mrms.mp.2022-0061. Epub ahead of print.
- Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer.
- Sun X, Liu K, Lu S, He W, Du Z.
- Cancers (Basel). 2022 Nov 6;14(21):5456. doi: 10.3390/cancers14215456.
- DNA Repair Mechanisms, Protein Interactions and Therapeutic Targeting of the MRN Complex.
- McCarthy-Leo C, Darwiche F, Tainsky MA.
- Cancers (Basel). 2022 Oct 27;14(21):5278. doi: 10.3390/cancers14215278.
- Replicative Instability Drives Cancer Progression.
- Morris BB, Smith JP, Zhang Q, Jiang Z, Hampton OA, Churchman ML, Arnold SM, Owen DH, Gray JE, Dillon PM, Soliman HH, Stover DG, Colman H, Chakravarti A, Shain KH, Silva AS, Villano JL, Vogelbaum MA, Borges VF, Akerley WL, Gentzler RD, Hall RD, Matsen CB, Ulrich CM, Post AR, Nix DA, Singer EA, Larner JM, Stukenberg PT, Jones DR, Mayo MW.
- Biomolecules. 2022 Oct 26;12(11):1570. doi: 10.3390/biom12111570.